Publications en collaboration avec des chercheurs de Hospital de Cruces (83)

2024

  1. Cognitive and brain connectivity trajectories in critically ill COVID-19 patients

    NeuroRehabilitation, Vol. 54, Núm. 3, pp. 359-371

  2. Extracorporeal Membrane Oxygenation and Cardiac Surgery in Acute Myocardial Infarction: Strategy for Cardiogenic Shock

    Journal of Cardiothoracic and Vascular Anesthesia

  3. Resistant fungal infection: a matter of importance not only in critical COVID patients

    Minerva Anestesiologica

2023

  1. Clinical relevance of timing of assessment of ICU mortality in patients with moderate-to-severe Acute Respiratory Distress Syndrome

    Scientific Reports, Vol. 13, Núm. 1

  2. Early routine use of V-A ECMO in patients with myocardial infarction and cardiogenic shock, is it a poor choice?

    Medicina Intensiva

  3. Heat stroke, future pandemic? Case report

    Revista Chilena de Anestesia, Vol. 52, Núm. 1, pp. 123-126

  4. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  5. Quantitative pupillometry in postoperative care after cardiac surgery: a precision tool

    Minerva Anestesiologica

  6. Reply to “Pulmonary aspergillosis in the intensive care unit: An underdiagnosed disease?”

    Medicina Intensiva

2022

  1. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181

  2. Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

    Journal of Intensive Care, Vol. 10, Núm. 1

  3. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

  4. Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

    Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89

2021

  1. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

  2. Limiting ICU admission from emergency services and wards

    Medicina Clinica, Vol. 157, Núm. 11, pp. 524-529

  3. Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function

    Pharmaceutics, Vol. 13, Núm. 10

2020

  1. Brain connectivity and cognitive functioning in individuals six months after multiorgan failure

    NeuroImage: Clinical, Vol. 25

  2. Changes of resistance rates in Pseudomonas aeruginosa strains are unrelated to antimicrobial consumption in ICU populations with invasive device-related infection

    Medicina Intensiva, Vol. 44, Núm. 7, pp. 399-408

  3. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 3, pp. 267-276

  4. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: Study protocol for a randomized controlled superiority trial

    Trials, Vol. 21, Núm. 1